When was Lungpacer founded?

Lungpacer was founded in 2009 and raised its 1st funding round 4 years after it was founded.

Where is Lungpacer located?

Lungpacer is headquartered in Vancouver, Canada. It is registered at 2900 - 550 Burrard Street, Vancouver.

How many employees does Lungpacer have?

As of Aug 31, 2026, the latest employee count at Lungpacer is 59.

Is Lungpacer a funded company?

Lungpacer is a funded company, having raised a total of $137M across 8 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 13, 2013.

When was the latest funding round of Lungpacer?

Lungpacer's latest funding was a $***** Series B round on Apr 23, 2026, with participation from 0 investor.

Where does Lungpacer rank among its competitors?

Lungpacer ranks 5th amongst 225 active competitors, of which 70 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Lungpacer, which secured $16M in Apr, 2026.

Who are the top competitors of Lungpacer?

Lungpacer's top competitors include ZOLL AEDs, InnAccel and vTitan. Among them, Lungpacer secured the most recent funding round in April, 2026.

Lungpacer - 2026 Company Profile, Funding & Competitors

Lungpacer is a series B company based in Vancouver (Canada), founded in 2009. It operates as a Developer of a neurostimulation-based pacer for diaphragm strength. Lungpacer has raised $137M in funding. The company has 225 active competitors, including 70 funded and 27 that have exited. Its top competitors include companies like ZOLL AEDs, InnAccel and vTitan.

Company Details

Developer of a neurostimulation-based pacer for diaphragm strength. It provides lungpacer system that uses a minimally invasive, transvascular nerve stimulation technology to activate the diaphragm. Its electrodes are intravenously inserted into the lungs to rhythmically activate the diaphragm through neurostimulation to restore negative pressure ventilation. The pacing therapy is used to prevent or reverse diaphragm muscle-disuse atrophy and maintain diaphragmatic endurance.

Website: lungpacer.com
Social
Registered Address: 2900 - 550 Burrard Street, Vancouver

Key Metrics

Founded Year

2009

Location

Vancouver, Canada

Stage

Series B

Total Funding

$137M in 8 rounds

Latest Funding Round

Series B, Apr 23, 2026, $*****

Investors

Valiance Asset Management & 7 more

Ranked

5^th among 225 active competitors

Employee Count

59 as on Aug 31, 2026

Similar Companies

Belluscura & 54 more

View Lungpacer's full profile

Lungpacer is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Lungpacer Medical, Inc. CIN: 718088-8 , Canada, Active	May 27, 2009	-	-	-

Lungpacer has raised a total funding of $137M over 8 rounds. Its first funding round was on Mar 13, 2013. Lungpacer has 8 institutional investors.

Here is the list of recent funding rounds of Lungpacer:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 23, 2026	3413125	Series B	3162561	1233194	5292259	9441617
Mar 18, 2025	4598496	Series B	1983559	9831950	9825958	3132566
Apr 13, 2022	9663890	Series B	7875883	8904491	2951542	6005296

Access funding benchmarks and valuations. Sign up today!

View details of Lungpacer's funding rounds and investors

Lungpacer's employee count trend

Lungpacer has 59 employees as of Aug 26. Here is Lungpacer's employee count trend over the years:

Uncover Lungpacer's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lungpacer include ZOLL AEDs, InnAccel and vTitan. Here is the list of Top 10 competitors of Lungpacer, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ZOLL AEDs 1983, Chelmsford (United States), Acquired	Developer of medical devices and software solutions for emergency care	-	Nobel Investments, Military Health & 2 others	64/100
2nd	InnAccel 2012, Bengaluru (India), Seed	Developer of medical devices for critical care, obstetrics, and neonatology	$5.84M	Mount Judi Ventures, Acunova Life Sciences ... & 29 others	60/100
3rd	vTitan 2010, Chengalpattu (India), Seed	Manufacturer of a broad range of medical devices used in critical care units of hospitals	$10M	Zoho & 10 others	58/100
4th	Pentax Medical 1976, Montvale (United States), Funding Raised	Manufacturer of endoscopic imaging devices	-	-	58/100
5th	Lungpacer 2009, Vancouver (Canada), Series B	Developer of a neurostimulation-based pacer for diaphragm strength	$137M	Valiance Asset Management, Canadian Institutes of Health Research ... & 6 others	57/100
6th	Ethypharm 1977, Saint Cloud (France), Acquired	Developer of therapies for the treatment of pain and addiction	$248M	Astorg Partners, Biovail & 7 others	55/100
7th	Belluscura 2015, Dallas (United States), Public	Provider of medical devices for laparoscopic procedures	$6.38M	Tekcapital	53/100
8th	MedInTech 2020, Hanam si (South Korea), Series B	Developer of medical device technologies	$21.2M	Smile Gate Investment, Atinum Investment & 7 others	51/100
9th	ALung 1997, Pittsburgh (United States), Acquired	Developer of extracorporeal CO2 removal system to supplement mechanical ventilation	$150M	Eagle Ventures, Birchmere Ventures & 14 others	49/100
10th	Blue Neem Medical Devices 2009, Bengaluru (India), Unfunded	Manufacturers of gastroenterology, nephrology, urology products	-	-	49/100